BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Jul 19, 2022 12:42pm

73 Views

Post# 34834723

BIOV VOLUME TRADE CHART OVER 350K ATS BEHIND DA CURTAIN BUY

C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com

12:40:51 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
BIOV - C	5.5	0.19	·	0.195	10.5	0.19	+0.015	8.6	205.0	33	59	0.16 0.19 0.16	0.65 0.09	12:17:26	Jul 04	15 min RT 2¢
CSE - C	5.5	0.19	·	0.195	10.5	0.19	+0.015	8.6	133.0	22	29	0.16 0.19 0.16	0.65 0.09	12:17:26		15 min
NEO ATS - U						0.19	+0.015	8.6	44.0	7	14	0.17 0.19 0.17		12:16:11		15 min
Omega - O						0.185	+0.01	5.7	12.5	2	5	0.165 0.19 0.165		12:06:44		15 min
CX2 - H						0.19	+0.015	8.6	14.8	2	7	0.17 0.19 0.17		12:16:11		15 min
CXD - D						0.175			0.0		1			Jul 04		15 min
TriAct - M						0.175			0.7		3					15 min